Navigation Links
Enbrelr Enters Safer Zone After Recent Research

Latest studies have declared ENBRELR (etanercept) safe to be used to treat psoriasis up to an extended period of two and half years//. The result of the current studies were presented at the 15th European Academy of Dermatology and Venereology (EADV)Congress . ENBREL is a 'Biologic Medicine which means it is synthesized using recombinant DNA or rDNA derived protein using current principles of biotechnology.

This biologic medicine acts by inhibiting one of the main mediators which triggers off inflammatory processes. Enbrel happens to be topmost biologic therapeutic clinically approved worldwide, It is also less cumbersome for patients as it is marketed in convenient 25mg and 50mg syringes making it most adaptable for treatment purposes.

Bruce Strober MD PhD, co director of the Psoriasis and Psoriatic Arthritis Center at New York University mentions that that these findings are very significant as it confirms the parameters within which Enbrel is safe to be used, and also provides valuable information regarding the use of other biologic medicines as well in the long run.

About 5.1 million people is affected by Psoriasis in U.K alone, according to statistics. The most common type of Psoriasis presents itself in the form of plaques over affected skin surface characterized by thickening of skin which looks reddish with superfluous flaky white scales which fall away on being scratched. Most common symptoms associated with these lesions are severe intolerable itching and redness of skin apart from the drying and scaling away of skin. It is probable that an abnormal response from the immune system of the body cause the skin cells to grow and multiply excessively.

In the 48 week Open Label study that was conducted it was clear that ENBREL produced no unpalatable side effects with extended dosages upto2.5 years when compared with randomized Placebo controlled Parent Studies. No further safety signals were iden tified. These findings support the conclusions derived from previous research done giving ENBREL50mg twice a week in a 96-week study.
MON
'"/>




Related medicine news :

1. More Doctors Suspended As Strike Enters Seventh Day
2. Doctors Strike In Andhra Enters The Second Day
3. Anti-Quota Stir: Stalemate Continues; Fast Enters 10th Day
4. AIIMS Strike Enters Second day, Support Continues To Pour In
5. JIPMER Strike Enters Eighth Day
6. The Food Pyramid Guide Enters Supermarkets
7. Vandetanib Study Enters Third Phase
8. Crucells Rabies MAb Enters Phase I Trial in India
9. Heart Surgery Is Getting Safer for the Old
10. Estrogen Patch is Safer than Pills for Heart
11. Traffic Violations Result in Safer Drivers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... , ... May 26, 2016 , ... ... clinical outcomes, hosted members and suppliers for its inaugural Member Conference at the ... their mission of elevating the operational health of America’s healthcare providers. , The ...
(Date:5/26/2016)... Washington, D.C. (PRWEB) , ... May 26, 2016 , ... ... the men and women who lost their lives in military battle for the country. ... discount cards in 2015 to provide more programs that empower independence for disabled military ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 million people ... cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world will gather ... Day®. , National Cancer Survivors Day® is an annual worldwide Celebration of Life ...
(Date:5/26/2016)... ... 2016 , ... Dr. James Maisel will present on “Macular ... on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. The presentation ... of New York , is a Board Certified ophthalmologist who completed his fellowship ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the unofficial ... is sharing tips to make sure your family and vehicle are ready to ... Council, there may be 439 deaths and an additional 50,500 serious injuries from motor ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... SAN FRANCISCO , May 27, 2016 ... biotechnology company focused on developing products for Regenerative Medicine, Neurology and ... Commissiong will be presenting at two upcoming investor conferences: ... Conference Center, 730 Third Avenue, New York City ... at 3:00pm Marcum MicroCap Conference   ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
Breaking Medicine Technology: